Annual report pursuant to Section 13 and 15(d)

SHAREHOLDERS' EQUITY - Required Shareholder Approval (Details)

v3.23.2
SHAREHOLDERS' EQUITY - Required Shareholder Approval (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 16, 2022
May 04, 2022
May 01, 2022
Jun. 30, 2022
Jun. 30, 2023
Jun. 15, 2022
May 31, 2022
Jun. 30, 2021
Class of Stock [Line Items]                
Common stock, shares authorized 100,000,000.0 40,000,000.0   100,000,000 100,000,000 40,000,000.0    
Warrants outstanding (In shares)       1,150,000 888,000     1,252,000
Reclassification of derivative liability to equity upon cure of authorized share deficiency       $ (35,025)        
Class A Warrants                
Class of Stock [Line Items]                
Proceeds from warrants issued       7,048        
Class B Warrants                
Class of Stock [Line Items]                
Warrants outstanding (In shares)             10,947,371  
Unrealized gain (loss) on derivatives $ 6,600              
Reclassification of derivative liability to equity upon cure of authorized share deficiency $ (35,000)              
Warrants outstanding             $ 41,600  
Proceeds from warrants issued       $ 39,094        
Registered Direct Offering 2022                
Class of Stock [Line Items]                
Number of shares issued   18,000,000.0 18,000,000.0          
Registered Direct Offering 2022 | Class A Warrants                
Class of Stock [Line Items]                
Pre-funded warrants to purchase shares of common stock   2,000,000.0            
Registered Direct Offering 2022 | Class B Warrants                
Class of Stock [Line Items]                
Warrants outstanding (In shares)         10,900,000      
Warrants exercised         0      
Warrants outstanding   $ 41,600